AUD17.75
0.45% day before yesterday
Australia, Sep 12, 08:10 am CET
ISIN
AU000000MMS5
Symbol
MMS

McMillan Shakespeare Target price 2025 - Analyst rating & recommendation

McMillan Shakespeare Classifications & Recommendation:

Buy
70%
Hold
30%

McMillan Shakespeare Price Target

Target Price AUD20.43
Price AUD17.75
Potential
Number of Estimates 7
7 Analysts have issued a price target McMillan Shakespeare 2026 . The average McMillan Shakespeare target price is AUD20.43. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 7 Analysts recommend McMillan Shakespeare to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the McMillan Shakespeare stock has an average upside potential 2026 of . Most analysts recommend the McMillan Shakespeare stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Revenue Million AUD 563.48 567.09
8.15% 0.64%
EBITDA Margin 43.65% 31.20%
1.41% 28.53%
Net Margin 16.92% 18.70%
5.51% 10.52%

8 Analysts have issued a sales forecast McMillan Shakespeare 2026 . The average McMillan Shakespeare sales estimate is

AUD567m
Unlock
. This is
0.64% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD630m 11.75%
Unlock
, the lowest is
AUD529m 6.20%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 AUD563m 8.15%
2026
AUD567m 0.64%
Unlock
2027
AUD588m 3.71%
Unlock
2028
AUD610m 3.64%
Unlock
2029
AUD623m 2.23%
Unlock
2030
AUD635m 1.92%
Unlock

8 Analysts have issued an McMillan Shakespeare EBITDA forecast 2026. The average McMillan Shakespeare EBITDA estimate is

AUD177m
Unlock
. This is
28.08% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD202m 17.74%
Unlock
, the lowest is
AUD160m 35.11%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 AUD246m 9.68%
2026
AUD177m 28.08%
Unlock
2027
AUD185m 4.47%
Unlock
2028
AUD192m 4.09%
Unlock
2029
AUD203m 5.71%
Unlock
2030
AUD209m 2.91%
Unlock
2031
AUD212m 1.09%
Unlock
2032
AUD217m 2.77%
Unlock

EBITDA Margin

2025 43.65% 1.41%
2026
31.20% 28.53%
Unlock
2027
31.43% 0.74%
Unlock
2028
31.56% 0.41%
Unlock
2029
32.64% 3.42%
Unlock
2030
32.95% 0.95%
Unlock

8 McMillan Shakespeare Analysts have issued a net profit forecast 2026. The average McMillan Shakespeare net profit estimate is

AUD106m
Unlock
. This is
11.20% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD113m 18.55%
Unlock
, the lowest is
AUD97.3m 2.01%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 AUD95.3m 14.11%
2026
AUD106m 11.20%
Unlock
2027
AUD111m 4.64%
Unlock
2028
AUD119m 6.82%
Unlock
2029
AUD124m 4.70%
Unlock
2030
AUD126m 1.80%
Unlock

Net Margin

2025 16.92% 5.51%
2026
18.70% 10.52%
Unlock
2027
18.86% 0.86%
Unlock
2028
19.44% 3.08%
Unlock
2029
19.91% 2.42%
Unlock
2030
19.89% 0.10%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Earnings Per Share AUD 1.37 1.53
15.13% 11.68%
P/E 11.63
EV/Sales 3.28

8 Analysts have issued a McMillan Shakespeare forecast for earnings per share. The average McMillan Shakespeare EPS is

AUD1.53
Unlock
. This is
11.68% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
AUD1.63 18.98%
Unlock
, the lowest is
AUD1.40 2.19%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 AUD1.37 15.13%
2026
AUD1.53 11.68%
Unlock
2027
AUD1.60 4.58%
Unlock
2028
AUD1.71 6.88%
Unlock
2029
AUD1.79 4.68%
Unlock
2030
AUD1.82 1.68%
Unlock

P/E ratio

Current 12.96 5.18%
2026
11.63 10.24%
Unlock
2027
11.11 4.47%
Unlock
2028
10.40 6.39%
Unlock
2029
9.94 4.42%
Unlock
2030
9.76 1.81%
Unlock

Based on analysts' sales estimates for 2026, the McMillan Shakespeare stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.31 11.07%
2026
3.28 0.77%
Unlock
2027
3.17 3.57%
Unlock
2028
3.06 3.51%
Unlock
2029
2.99 2.19%
Unlock
2030
2.93 1.88%
Unlock

P/S ratio

Current 2.18 1.67%
2026
2.17 0.64%
Unlock
2027
2.09 3.58%
Unlock
2028
2.02 3.51%
Unlock
2029
1.97 2.18%
Unlock
2030
1.94 1.88%
Unlock

Current McMillan Shakespeare Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BELL POTTER SECURITIES
Locked
Locked
Locked Jul 02 2025
CANACCORD GENUITY
Locked
Locked
Locked May 25 2025
MACQUARIE RESEARCH
Locked
Locked
Locked Mar 18 2025
BELL POTTER SECURITIES
Locked
Locked
Locked Mar 03 2025
CANACCORD GENUITY
Locked
Locked
Locked Feb 26 2025
CANACCORD GENUITY
Locked
Locked
Locked Dec 12 2024
MACQUARIE RESEARCH
Locked
Locked
Locked Nov 20 2024
Analyst Rating Date
Locked
BELL POTTER SECURITIES:
Locked
Locked
Jul 02 2025
Locked
CANACCORD GENUITY:
Locked
Locked
May 25 2025
Locked
MACQUARIE RESEARCH:
Locked
Locked
Mar 18 2025
Locked
BELL POTTER SECURITIES:
Locked
Locked
Mar 03 2025
Locked
CANACCORD GENUITY:
Locked
Locked
Feb 26 2025
Locked
CANACCORD GENUITY:
Locked
Locked
Dec 12 2024
Locked
MACQUARIE RESEARCH:
Locked
Locked
Nov 20 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today